FDA to approve shared system REMS for TIRF products
The U.S. Food and Drug Administration today approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release fentanyl (TIRF) products.
- Skechers Will Pay $40 Million to Settle FTC Charges That It Deceived Consumers with Ads for "Toning Shoes"
- Five Retailers Agree to Stop Sale and Recall Tots in Mind Crib Tents Due to Strangulation and Entrapment Hazard
- Bakery El Monte Sinai Corp Announces Allergy Alert on Undeclared Eggs in Rainbow Cake
- Order FREE Healthy Women’s Action Kit
- Debt Collectors Settle with FTC, Agree to Stop Deceiving and Abusing Consumers
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!
You must be logged in to post a comment.